Product Code: GNR
FDA class 1
21 CFR 866.3330
Antisera, Neutralization, Influenza Virus A, B, C
Microbiology
The Neutralization Antisera for Influenza Virus A, B, and C are reference reagents used in virus neutralization assays to identify and subtype influenza virus isolates from clinical specimens, supporting surveillance and diagnosis of influenza infections. It is classified as FDA Class 1 (lowest risk) and is subject only to general controls. The product code is GNR, regulated under 21 CFR 866.3330 in the Microbiology specialty.
510(k)s
1
FEI Numbers
0
Registration Numbers
0
Unique Applicants
1
Years Active
—
Research product code GNR in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- GNR
- Device Class
- FDA class 1
- Regulation Number
- 866.3330
- Medical Specialty
- Microbiology
- Review Panel
- MI
- Submission Type
- 4
Device Characteristics
✗
GMP Exempt
✗
Implant
✗
Life Sustain/Support
✗
Third Party
—
Summary Malfunction Reporting
510(k) Clearance History
Loading...
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K984596 | VIRASTAT FITC-LABELED ANTI-INFLUENZA A AND B MONOCLONAL ANTIBODIES | Mar 04, 1999 | Substantially Equivalent | Zymetx, Inc. |